Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$30,000.00
Jan 20, 2025
For-profit organization
IP Assist: Intellectual Property Strategy Engagement
1027023
The project will support development of intellectual property capacity within the firm.
$75,000.00
Sep 2, 2024
For-profit organization
MNC Collab - DispersinB Wound Gel - DispersinB Wound Gel Development and Commercialization
1022709
As part of Multinational Corporate Collaboration Program, the project “DispersinB Wound Gel Development and Commercialization” will focus on scaling up the manufacturing process for DispersinB Wound Gel and ensuring the product meets specifications. The DispersinB Wound Gel is a combination product (device, drug, biologic) that is first of its kind in wound care as it disperses biofilms enzymatically.
$200,000.00
Aug 1, 2024
For-profit organization
The development of supplemental products to Kane's revyve Antimicrobial Wound Gel for the wound care market.
1021203
The Design and Development of products based on the revyve Antimicrobial Wound Gel. The sterile wound gel, primarily intended to be used in surgical rooms for post surgery infection prevention; the spray wound gel, primarily intended to be used for large surface burn wounds to clear any existing infection and protect from subsequent infection. Application and removal wound be contactless for these sensitive wounds; and the wound cleanser that is intended to be used prior to debridement and treatment with the revyve wound gel as part of a wound management regimen. The project involves all stages of development for all products, from conception to design transfer.
$23,000.00
May 31, 2024
For-profit organization
Kane Biotech Inc.-2024-2025-1026259
1026259
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
$74,490.00
Nov 15, 2022
For-profit organization
Development of Commercial Scale DispersinB® Production Method
997959
To develop a cost-effective fermentation and purification manufacturing process for DispersinB®
$27,000.00
Jun 23, 2022
For-profit organization
Kane Biotech Inc.-2022-2023-995271
995271
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
$54,750.00
May 7, 2020
For-profit organization
Consumer test of Kane's human health shampoo in the US and international expansion of animal health product lines.
952412
Consumer test of Kane's human anti-biofilm shampoo in the West and Northeast submarkets of the US and expansion of Kane's animal health business to international markets with a high or growing demand for animal healthcare products.
$340,680.00
Oct 7, 2019
For-profit organization
Development of Quality and Supply Chain Resources
935380
Kane Biotech Inc. is undertaking a strategy to build commercial supply chain and quality control capabilities for proprietary products.
$2,491,266.00
Aug 6, 2019
For-profit organization
000015555
000015555
Commercialize a wound gel treatment
$3,792,984.00
Aug 6, 2019
For-profit organization
000015555
000015555
Commercialize a wound gel treatment